Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02369523 · ClinicalTrials.gov registry record · Early Phase 1
Multimodal Pain Management Following Primary TKA
A Early Phase 1 study, sponsored by University of Utah.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 84
- Enrollment target
NCT02369523: Clinical Trial Early Phase 1 study, sponsored by University of Utah.
NCT02369523 is a Early Phase 1 study that was terminated before completion, run by University of Utah. The registered enrollment target is 84 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (58% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02369523, a Early Phase 1 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 84 participants
- Enrollment target
Study Summary
The investigators plan to evaluate the length of time to discharge readiness between the groups (continuous femoral nerve blocks (cFNB) vs. liposomal bupivacaine (LB) vs. periarticular infusion cocktails (PIC) following primary total knee arthroplasty (TKA). In addition, the investigators will compare quadriceps strength recovery over time and exploratory variables between the groups.
Primary Outcome
Time to discharge readiness will be defined as the time from surgical stop to the time of the 2nd consecutive assessment where all criteria are fulfilled.
Interventions
- DRUG Bupivacaine
- DRUG Exparel
- DRUG Ropivacaine cocktail (PIC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-04 |
| Phase | Early Phase 1 |
Why NCT02369523 stopped before completion
NCT02369523 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (58% higher).
The record links to 0 conditions, and to 3 interventions - of which Bupivacaine is the first listed.
NCT02369523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02369523 about?
NCT02369523 is a clinical study titled "Multimodal Pain Management Following Primary TKA". The investigators plan to evaluate the length of time to discharge readiness between the groups (continuous femoral nerve blocks (cFNB) vs. liposomal bupivacaine (LB) vs. periarticular infusion cocktails (PIC) following primary total knee arthroplasty (TKA). In addition, the investigators will compa...
What is the current status of trial NCT02369523?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 84 participants. The study started on 2014-09. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02369523?
The interventions under investigation include: Bupivacaine (DRUG), Exparel (DRUG), Ropivacaine cocktail (PIC) (DRUG).
Who is sponsoring clinical trial NCT02369523?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02369523's enrollment target sits among peer trials
84 261st of 2000 higher than 1,737 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia